{"id":"https://genegraph.clinicalgenome.org/r/ab306431-8735-45a3-a6f3-3ae8803da293v1.0","type":"EvidenceStrengthAssertion","dc:description":"EPCAM was first reported in relation to autosomal dominant Lynch Syndrome (MONDO:0005835) in 2009 by two publications (Ligtenberg MJ et al., PMID:19098912 and Kovacs ME et. al. PMID:19177550).  EPCAM deletions involved in Lynch Syndrome are also frequently described in literature as associated with Hereditary Non-Polyposis Colorectal Cancer 8 (HNPCC8, MONDO:0013196) a similar disorder. Five variants, all large deletions spanning the 8th and 9th exon of EPCAM into the intergenic region prior to the MSH2 promoter,  reported in 6 probands across 3 publications were curated.  Many additional publications describe similar deletions in tumor sequencing cohorts. However, the maximum score for genetic evidence has been reached (12 points). The EPCAM deletions spanning the 8th and 9th exon and intergenic space cause hypermethylation at the MSH2 promoter, which causes a decrease or complete loss of MSH2 expression. It is important to note that loss of the EPCAM gene itself has not been definitively associated with Lynch Syndrome / HNPCC8. Complete absence of EPCAM protein expression through recessive truncating mutations causes an apparently unrelated syndrome â€“ congenital tufting enteropathy. EPCAM protein expression or absence does not bear literature evidence in isolation to support a causal role in Lynch Syndrome / HNPCC8 in the absence of disruption of MSH2. The specific deletions spanning EPCAM into the intergenic space of MSH2 are a distinct mutation type with promoter methylation regulatory effects on MSH2 expression. This gene-disease association is also supported by experimental evidence (2.5 points) showing EPCAM tissue expression in glandular cells of glandular cells of the duodenum, small intestine, colon and rectum (though not expressed in the endothelial cells of the colon), as well as MSH2 immunohistochemistry assays showing loss of MSH2 expression with EPCAM deletions, and promoter hypermethylation in cells carrying these characteristic deletions (PMIDs: 24309898, 19177550, 19098912). In summary, EPCAM deletions spanning the last exons of EPCAM to the intergenic region prior to MSH2 promoter are definitively associated (14.5 points) with Lynch Syndrome / HNPCC8. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. ","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/ab306431-8735-45a3-a6f3-3ae8803da293","GCISnapshot":"https://genegraph.clinicalgenome.org/r/3c071c7e-ba5c-46c7-b46b-fee6acf3a43f","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/3c071c7e-ba5c-46c7-b46b-fee6acf3a43f_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2022-06-20T17:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/3c071c7e-ba5c-46c7-b46b-fee6acf3a43f_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2022-06-20T20:37:53.932Z","role":"Publisher"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3c071c7e-ba5c-46c7-b46b-fee6acf3a43f_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ee471e79-844c-4b74-b5df-2a0283cdb290","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ee471e79-844c-4b74-b5df-2a0283cdb290_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Tumors display microsatellite instability ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/ee471e79-844c-4b74-b5df-2a0283cdb290_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23530899","allele":{"id":"https://genegraph.clinicalgenome.org/r/1555e64e-3c26-46e7-b1d5-dea675c2d4a8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000002.12:g.47382537_47391209del (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2497030040"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/6de0df3b-94a2-4aae-92e7-939f543161cc","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6de0df3b-94a2-4aae-92e7-939f543161cc_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Microsatellite instable tumor and loss of MSH2 expression ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/6de0df3b-94a2-4aae-92e7-939f543161cc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23530899","allele":{"id":"https://genegraph.clinicalgenome.org/r/1555e64e-3c26-46e7-b1d5-dea675c2d4a8"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/15e81680-6bd0-452e-a8cb-328e9d51298d","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/15e81680-6bd0-452e-a8cb-328e9d51298d_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Microsatellite instability high in tumors, and loss of MSH2 expression by immunohistochemistry ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/15e81680-6bd0-452e-a8cb-328e9d51298d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19177550","allele":{"id":"https://genegraph.clinicalgenome.org/r/4e770bd9-4ceb-41aa-b09e-f5945ed024fb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000002.12:g.47384470_47390527del (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2497030050"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/c6508a8f-23fb-4115-b967-aaa61aca6c01","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c6508a8f-23fb-4115-b967-aaa61aca6c01_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Microsatellite instability high in tumors ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/c6508a8f-23fb-4115-b967-aaa61aca6c01_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19177550","allele":{"id":"https://genegraph.clinicalgenome.org/r/fcbe9189-2651-49a8-a9f3-d3434e518d17","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000002.12:g.47382447_47391120del (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2497030049"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/3c071c7e-ba5c-46c7-b46b-fee6acf3a43f_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4ebb6163-33e9-4b4a-b233-228b9331bb6c_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19098912","rdfs:label":"Family A","estimatedLodScore":1.81,"family":{"id":"https://genegraph.clinicalgenome.org/r/4ebb6163-33e9-4b4a-b233-228b9331bb6c","type":"Family","rdfs:label":"Family A","member":{"id":"https://genegraph.clinicalgenome.org/r/420c139b-d051-4622-8c5f-b13930703a57","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19098912","rdfs:label":"A:IV:1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":47,"allele":{"id":"https://genegraph.clinicalgenome.org/r/4121af1b-dedd-4f7b-bf7f-a69114fa6fa2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002354.2(EPCAM):c.859-1462_*1999del","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA256545"}},"firstTestingMethod":"PCR","phenotypeFreeText":"Colon cancer noted twice at age 47. Loss of MSH2 in immunohistochemistry ","phenotypes":"obo:HP_0003003","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/54c02b7e-1cad-414a-9d3e-ca6c24900afb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19098912","allele":{"id":"https://genegraph.clinicalgenome.org/r/4121af1b-dedd-4f7b-bf7f-a69114fa6fa2"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":6,"proband":{"id":"https://genegraph.clinicalgenome.org/r/420c139b-d051-4622-8c5f-b13930703a57"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/42930f96-c102-469b-9d1b-fe27873d98bb_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19177550","rdfs:label":"HFC121","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/42930f96-c102-469b-9d1b-fe27873d98bb","type":"Family","rdfs:label":"HFC121","member":{"id":"https://genegraph.clinicalgenome.org/r/7bd3d910-1832-4d28-804e-8b5b8491f27a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19177550","rdfs:label":"HFC121_III-1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":31,"allele":{"id":"https://genegraph.clinicalgenome.org/r/4e770bd9-4ceb-41aa-b09e-f5945ed024fb"},"firstTestingMethod":"PCR","phenotypes":"obo:HP_0003003","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/15e81680-6bd0-452e-a8cb-328e9d51298d_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":3,"phenotypes":"obo:HP_0003003","proband":{"id":"https://genegraph.clinicalgenome.org/r/7bd3d910-1832-4d28-804e-8b5b8491f27a"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/285ecabc-06a4-49c5-b063-461a39ffe2b5_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23530899","rdfs:label":"Family B","family":{"id":"https://genegraph.clinicalgenome.org/r/285ecabc-06a4-49c5-b063-461a39ffe2b5","type":"Family","rdfs:label":"Family B","ethnicity":{"id":"cg:HispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/7ad47c65-e119-4d58-84f2-4817af9fadef","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23530899","rdfs:label":"FamilyB_III-1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":45,"allele":{"id":"https://genegraph.clinicalgenome.org/r/1555e64e-3c26-46e7-b1d5-dea675c2d4a8"},"ethnicity":{"id":"cg:HispanicOrLatino"},"firstTestingMethod":"PCR","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/6de0df3b-94a2-4aae-92e7-939f543161cc_variant_evidence_item"}}},"phenotypePositiveAllelePositive":4,"proband":{"id":"https://genegraph.clinicalgenome.org/r/7ad47c65-e119-4d58-84f2-4817af9fadef"}},{"id":"https://genegraph.clinicalgenome.org/r/a6da962b-6344-4142-a3f3-4925709ae3ea_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19177550","rdfs:label":"HFC073","family":{"id":"https://genegraph.clinicalgenome.org/r/a6da962b-6344-4142-a3f3-4925709ae3ea","type":"Family","rdfs:label":"HFC073","member":{"id":"https://genegraph.clinicalgenome.org/r/abaac496-3642-4c9b-a1fb-851f5b69e716","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19177550","rdfs:label":"II-I","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":34,"allele":{"id":"https://genegraph.clinicalgenome.org/r/fcbe9189-2651-49a8-a9f3-d3434e518d17"},"firstTestingMethod":"PCR","phenotypeFreeText":"Colon cancer","phenotypes":"obo:HP_0003003","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/c6508a8f-23fb-4115-b967-aaa61aca6c01_variant_evidence_item"}}},"phenotypeFreeText":"Colon cancer","phenotypePositiveAllelePositive":2,"phenotypes":"obo:HP_0003003","proband":{"id":"https://genegraph.clinicalgenome.org/r/abaac496-3642-4c9b-a1fb-851f5b69e716"}},{"id":"https://genegraph.clinicalgenome.org/r/df5c08d0-c1d5-4ec5-a3ee-9084602e4aa1_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23530899","rdfs:label":"Family A","estimatedLodScore":0.9,"family":{"id":"https://genegraph.clinicalgenome.org/r/df5c08d0-c1d5-4ec5-a3ee-9084602e4aa1","type":"Family","rdfs:label":"Family A","ethnicity":{"id":"cg:HispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/f934ed2a-4842-49ef-859e-dd6e6ef9f934","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23530899","rdfs:label":"FamilyA_III=4","allele":{"id":"https://genegraph.clinicalgenome.org/r/1555e64e-3c26-46e7-b1d5-dea675c2d4a8"},"ethnicity":{"id":"cg:HispanicOrLatino"},"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/ee471e79-844c-4b74-b5df-2a0283cdb290_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":3,"proband":{"id":"https://genegraph.clinicalgenome.org/r/f934ed2a-4842-49ef-859e-dd6e6ef9f934"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/c5ac04ac-d9ae-4f6e-8945-f82e35b88f59_family_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23530899","rdfs:label":"Family C ","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/c5ac04ac-d9ae-4f6e-8945-f82e35b88f59","type":"Family","rdfs:label":"Family C ","ethnicity":{"id":"cg:HispanicOrLatino"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"1 ductal carcinoma found in additional to affected with colorectal cancer noted ","phenotypePositiveAllelePositive":2,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/fe954bf8-55e8-4ec2-8221-645aca4d0d82_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19098912","rdfs:label":"HK Family A","estimatedLodScore":0.9,"family":{"id":"https://genegraph.clinicalgenome.org/r/fe954bf8-55e8-4ec2-8221-645aca4d0d82","type":"Family","rdfs:label":"HK Family A","member":{"id":"https://genegraph.clinicalgenome.org/r/37b6d2a9-1ae3-4da6-bacf-90f563c7c8b9","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19098912","rdfs:label":"II-1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":30,"allele":{"id":"https://genegraph.clinicalgenome.org/r/cf80ea10-161b-41e5-8a36-96953f0770e6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NR_030286.1(MIR559):n.278_23134del","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/12776"}},"firstTestingMethod":"PCR","phenotypes":"obo:HP_0003003","previousTesting":true,"previousTestingDescription":"Chan et al 2006 (PMID 16951683) identified methylation / promoter disruption at MSH2 for affected family members, but did not identify the cause being the 22 KB deletion.  \n","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/e2b8f037-080c-4866-97c6-2e6a89543f74_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19098912","allele":{"id":"https://genegraph.clinicalgenome.org/r/cf80ea10-161b-41e5-8a36-96953f0770e6"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0003003","obo:HP_0012114"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/37b6d2a9-1ae3-4da6-bacf-90f563c7c8b9"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/54c02b7e-1cad-414a-9d3e-ca6c24900afb","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/54c02b7e-1cad-414a-9d3e-ca6c24900afb_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Loss of MSH2, Microsatellite Instable tumors","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/54c02b7e-1cad-414a-9d3e-ca6c24900afb_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/e2b8f037-080c-4866-97c6-2e6a89543f74","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e2b8f037-080c-4866-97c6-2e6a89543f74_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"MSH2 promoter disruption, Fusion transcript of EPCAM and MSH2 amplified in family members with the mutation.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/e2b8f037-080c-4866-97c6-2e6a89543f74_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/3c071c7e-ba5c-46c7-b46b-fee6acf3a43f_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3c071c7e-ba5c-46c7-b46b-fee6acf3a43f_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d22b211d-2f18-4e0c-9e5c-c01faf4bb09d","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1f54d85f-45b1-42fb-ab3a-773076352746","type":"FunctionalAlteration","dc:description":"Promoter methylation testing displayed higher percent of promoter methylation and increased EPCAM positive (carrying the deletion of EPCAM exon 8 through upstream of MSH2) cells in colorectal tumors vs normal tissue. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19098912","rdfs:label":"MSH2 Promoter Methylation "}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/3c071c7e-ba5c-46c7-b46b-fee6acf3a43f_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5b6ad97f-8692-4688-b0ed-b581cbc09b93","type":"EvidenceLine","dc:description":"This assay (MSH2 IHC) is replicated across multiple papers. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2fb12758-b55a-47c6-901a-b3243f6b2f79","type":"Finding","dc:description":"Immunohistochemistry staining shows loss of MSH2 in colorectal adenocarcinoma cells, without loss of MSH2 in stromal cells or loss of other MMR genes such as MLH1. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19177550","rdfs:label":"MSH2 Immunohistochemistry ","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/2ed044ec-7797-4826-b62a-80a9be9aee62","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e435d5e4-d0c0-4dfb-b98d-26a83cc06a4e","type":"Finding","dc:description":"EPCAM is expressed in the glandular cells of the duodenum, small intestine, colon and rectum, though not expressed in the endothelial cells of the colon. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24309898","rdfs:label":"EPCAM Protein Expression ","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2.5}],"evidenceStrength":"Definitive","sequence":4589,"specifiedBy":"GeneValidityCriteria9","strengthScore":14.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/ZqrbBk8t6Mc","type":"GeneValidityProposition","disease":"obo:MONDO_0005835","gene":"hgnc:11529","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_3c071c7e-ba5c-46c7-b46b-fee6acf3a43f-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}